120 related articles for article (PubMed ID: 37703478)
21. Whole-body (99m)Tc-octreotide scintigraphy with SPECT/CT to detect occult tumor inducing paraneoplastic osteomalacia.
Rodrigues NR; Calich AL; Etchebehere M; Ichiki WA; Pereira FP; Amstalden EM; de Sa Etchebehere EC
Clin Nucl Med; 2015 Jan; 40(1):54-7. PubMed ID: 24458181
[TBL] [Abstract][Full Text] [Related]
22. (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO).
Sun H; Jiang XF; Wang S; Chen HY; Sun J; Li PY; Ning G; Zhao YJ
Endocrine; 2007 Jun; 31(3):305-10. PubMed ID: 17906380
[TBL] [Abstract][Full Text] [Related]
23. Concordance between whole-body scintigraphy 111In-octreotide and 99mTc-sestamibi uptake in the detection of four tumor-induced osteomalacia cases.
Ferraz MP; Watanabe T; Sado HN; Ono CR; Buchpiguel CA; Correa PH; Martin RM
J Clin Endocrinol Metab; 2014 Mar; 99(3):699-700. PubMed ID: 24423352
[No Abstract] [Full Text] [Related]
24. Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
Li Y; Si JM; Zhang J; Du J; Wang F; Jia B
World J Gastroenterol; 2005 Jul; 11(25):3953-7. PubMed ID: 15991301
[TBL] [Abstract][Full Text] [Related]
25. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
Korde A; Mallia M; Shinto A; Sarma HD; Samuel G; Banerjee S
Cancer Biother Radiopharm; 2014 Nov; 29(9):387-94. PubMed ID: 25379612
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
[TBL] [Abstract][Full Text] [Related]
27. Culprit Tumor as an Unexpected Extraosseous MDP Activity on Bone Scintigraphy in a Patient With Tumor-Induced Osteomalacia.
Xia X; Shao F; Hu F; Gai Y; Lan X
Clin Nucl Med; 2020 Jun; 45(6):492-494. PubMed ID: 32366790
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of
Xu J; Li Y; Xu X; Zhang J; Zhang Y; Yu X; Huang D
Ann Nucl Med; 2018 Aug; 32(7):446-452. PubMed ID: 29926342
[TBL] [Abstract][Full Text] [Related]
29. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
Vukomanovic VR; Matovic M; Doknic M; Ignjatovic V; Simic Vukomanovic I; Djukic S; Peulic M; Djukic A
Nucl Med Commun; 2019 Jan; 40(1):41-51. PubMed ID: 30334858
[TBL] [Abstract][Full Text] [Related]
31. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
32. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
33. Osteoblastoma as a cause of osteomalacia assessed by bone scan.
Chun KA; Cho IH; Won KJ; Lee HW; Choi JH; Ahn JC; Shin DS
Ann Nucl Med; 2003 Jul; 17(5):411-4. PubMed ID: 12971642
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
35. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
Nucl Med Commun; 2013 Mar; 34(3):249-53. PubMed ID: 23276828
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients.
Jadhav S; Kasaliwal R; Shetty NS; Kulkarni S; Rathod K; Popat B; Kakade H; Bukan A; Khare S; Budyal S; Jagtap VS; Lila AR; Bandgar T; Shah NS
J Clin Endocrinol Metab; 2014 Sep; 99(9):3049-54. PubMed ID: 24960541
[TBL] [Abstract][Full Text] [Related]
37. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
[TBL] [Abstract][Full Text] [Related]
38. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
[TBL] [Abstract][Full Text] [Related]
39. Cardiac pheochromocytomas detected by Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) scintigraphy.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
Clin Nucl Med; 2007 Mar; 32(3):182-5. PubMed ID: 17314591
[TBL] [Abstract][Full Text] [Related]
40. Incidental Synchronous
Roshanravan V; Soltani E; Hasanzadeh Haddad E; Sadeghi R; Sahebkari A; Mottaghi M; Aghaee A
Asia Ocean J Nucl Med Biol; 2022; 10(2):138-141. PubMed ID: 35800421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
